Male “manopause” and testosterone

All of us guys want to stay young, have terrific muscle builds and think of ourselves as studs. However, the facts don’t support this desire. With aging comes a loss of a lot of male ego along with other items. Thus, the introduction of male “menopause” and the burst of therapies aimed at susceptible male subjects bent on improving their performance.

Glenn Braunstein, MD, MACP, professor of medicine at Cedars-Sinai in Los Angeles explained his opinion on this matter in the ...

Continue Reading →

Updated opinion on Vitamin D controversy

While on a recent trip I had the opportunity to read an article in the American Medical Athletic Association journal (Spring edition, 2014) written by Dr. Alan Roth, PhD.  Dr. Roth refers to studies and papers written by Dr. John J. Cannell, MD who is described as a “frontier of vitamin D research and is the executive of the Vitamin D Council”. While this article pertains mainly to athletes, I believe it is adaptable to the average citizen as well. ...

Continue Reading →


Naturally, one of my most common patient concerns is shortness of breath.

There is, however, one unique situation that is surprisingly common. In fact, I will often see several new patients every week that I have come to conclude that they share this common diagnosis.

These individuals often experience similar sensations of “not being able to take in a full, satisfying deep breath”, “feeling like they are not getting enough oxygen”, “not being able to fully expand their lungs”, “yawning or sighing ...

Continue Reading →

GERD and lung disease

In the March 2014 edition of ACP Internist (American College of Physicians News for Internist publication)  an excellent article by Leah Lawrence  described what is known and not known between a possible link from gastroesophageal reflux disorder (GERD) and pulmonary diseases.  GERD can be asymptomatic and, thus, missed as a possible link to a patient’s pulmonary symptoms. A variety of lung diseases are associated with GERD: asthma, aspiration pneumonia, chronic cough and even idiopathic pulmonary fibrosis (IPF) have been linked. ...

Continue Reading →

The $99 Personal Genomic Service

The Annals of Internal Medicine reported this April of 2014 (Volume 160, number 7, page 507-509) that there is a concern amongst academic medicine as to the value and direction that some laboratories are provided when testing an individual’s genetic background.  Rather surprisingly, I was about to have my own saliva tested. This was prompted by a patient of mine who told me about his testing and how much he enjoyed learning about his genetic “tree”. Then this article arrived ...

Continue Reading →

Problems importing medications from India?

The Wall Street Journal, Asian edition, on February 17, 2014 had an article written by Gardiner Harris from New Delhi titled “Medicines from India set off safety fears”.  This is a hotly debated issue. On the one side, India’s pharmaceutical industry is coming under scrutiny from American regulators looking into prescription drugs. The concern for the American consumer is whether or not there are “safety lapses, falsified drug testing results and the sale of fake medications”.  From the American Food ...

Continue Reading →

Using CT scan of the chest to screen for lung cancer

It is not uncommon to be asked by a patient who has been, or still is, a cigarette smoker whether or not to have a CT scan of the chest.

In the past chest X-rays have been the standard consideration of monitoring a high risk patient for the early detection of a “shadow” that may become a lung mass and a cancer. Early detection of lung cancer offers the best hope for a successful and optimistic outlook.

In the Annals of Internal ...

Continue Reading →

Which medication wins the battle in COPD?

There is always one drugs trying to stake its place as being better than another. A new report suggests that tiotropium (Spiriva) may be “better” than a rival long-acting bronchodilator, salmetrol (Serevent), in a head-to-head comparison. What the “battle” was about was the length of time to having an exacerbation of COPD related symptoms (cough, sputum production, bronchitis, etc). The tiotropium brand had a longer time to exacerbation (187 days) than the salmetrol (145 days).

One word of caution, however, was ...

Continue Reading →

Green tea and heart disease

Research has shown a 10% reduction in heart disease in patients who consume one cup of green tea a day. The same benefit does not seem to be present with consumption of black tea.

Continue Reading →

Vitamin D and heart disease

New examination of patient data has disclosed evidence suggesting that vitamin D levels may play a highly significant role in cardiovascular health. This was according to an article published in the American Journal of Cardiology (October 2010).
Jeffrey L. Anderson, M.D., of the Intermountain Medical Center in Murray, Utah, and colleagues analyzed 41,504 patient records. Vitamin D levels were reviewed as well as heart conditions to see if there was an association.
The researchers found a 63.6 percent prevalence of ...

Continue Reading →
Page 1 of 4 1234